TCT 2022: SYMPLICITY HTN-3 trial data show sustained long-term blood pressure reductions with Medtronic renal denervation procedure ...Middle East

Long-term analysis from landmark renal denervation trial presented as Late Breaking Clinical Science, published simultaneously in The Lancet Data add to growing body of evidence supporting the durability of the Symplicity blood pressure procedure DUBLIN and BOSTON, Sept. 18, 2022...

Hence then, the article about tct 2022 symplicity htn 3 trial data show sustained long term blood pressure reductions with medtronic renal denervation procedure was published today ( Sunday 18/09/2022 - 06:48 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( TCT 2022: SYMPLICITY HTN-3 trial data show sustained long-term blood pressure reductions with Medtronic renal denervation procedure )

Also on site :

• Trump endorses Steven Hilton in California governor's race
• I Asked Dietitians What Women Over 50 Are Getting Wrong About Their Diets, and They All Said the Same 2 Things
• This 1954 Film Ranked as Alfred Hitchcock's No. 1 'Masterpiece'